a developer of gene therapy products for patients with serious rare diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with KMSTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then KMSTF could also see price increases.
Ticker / NAME | Correlation To BOLD | 1D Price Change % | ||
---|---|---|---|---|
BOLD | 100% | -9.24% | ||
KMSTF - BOLD | 56% Loosely correlated | N/A | ||
TNXP - BOLD | 33% Poorly correlated | -0.85% | ||
KOD - BOLD | 32% Poorly correlated | -3.64% | ||
BIOR - BOLD | 28% Poorly correlated | -4.42% | ||
AKBA - BOLD | 25% Poorly correlated | -3.12% | ||
More |
Ticker / NAME | Correlation To BOLD | 1D Price Change % |
---|---|---|
BOLD | 100% | -9.24% |
gene therapy theme (12 stocks) | 74% Closely correlated | -4.25% |
biotechnology theme (238 stocks) | 18% Poorly correlated | -1.76% |
drugs theme (254 stocks) | 15% Poorly correlated | -1.67% |